Novo gets much-needed lift as Wegovy pill tops Wall Street forecasts

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 04 Nov, 16:13 UTC

The drug’s third-quarter sales numbers came in well above consensus estimates, widening Novo’s early edge over Eli Lilly in the latest battleground for weight loss medicines.

science

Sources

• T2Novo gets much-needed lift as Wegovy pill tops Wall Street forecastsBioPharma Dive / Healthcare Dive / MedTech Dive04 Nov, 16:13